C.R. Bard, Inc. (New Jersey)
(NYSE : BCR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.14%107.570.6%$463.76m
TMOThermo Fisher Scientific Inc.
1.11%283.771.0%$450.58m
ABTAbbott Laboratories
-0.26%79.610.8%$313.34m
ISRGIntuitive Surgical, Inc.
1.33%518.032.4%$291.82m
BSXBoston Scientific Corporation
0.66%38.231.1%$286.68m
EWEdwards Lifesciences Corporation
0.53%227.291.2%$251.89m
SYKStryker Corporation
1.17%213.761.3%$238.49m
BDXBecton, Dickinson and Company
1.77%252.951.1%$237.90m
ALGNAlign Technology, Inc.
3.09%200.166.3%$232.01m
BAXBaxter International Inc.
0.46%88.011.7%$226.86m
PODDInsulet Corporation
-0.98%153.396.9%$161.71m
ZBHZimmer Biomet Holdings, Inc.
1.77%136.441.7%$143.34m
WATWaters Corporation
1.17%213.774.0%$124.80m
PENPenumbra, Inc.
2.27%145.958.7%$110.33m
ABMDABIOMED, Inc.
4.50%169.643.3%$105.68m

Company Profile

C.R. Bard, Inc. engages in the design, development, manufacture, distribution, and marketing of medical technologies in the fields of vascular, urology, oncology and surgical specialty products. It sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.